Biodegradable Microparticles for in vivo Glomerular Targeting: Implications for Gene Therapy of Glomerular Disease
暂无分享,去创建一个
N. Nahman | L. Brannon-Peppas | A. Johnson | V. Bergdall | U. Bhatt | Christopher J. Hickey | G. Hinkle | T. Sferra | W. Drost | J. Ellison | J. Bonagura | N. Shen | A. Mansfield | Aaron Haynam | P. Gamboa | S.-L. Shie
[1] N. Nahman,et al. Microsphere-adenoviral complexes target and transduce the glomerulus in vivo. , 2000, Kidney international.
[2] Philip R. Johnson,et al. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. , 2000, Human gene therapy.
[3] N. Nahman,et al. Successful DNA transfer in cultured human mesangial cells using replication deficient recombinant adenovirus. , 1998, Journal of Investigative Medicine.
[4] L. Fine. Gene transfer into the kidney: promise for unravelling disease mechanisms, limitations for human gene therapy. , 1996, Kidney international.
[5] H. Blau,et al. Gene therapy--a novel form of drug delivery. , 1995, The New England journal of medicine.